C4 Therapeutics, Inc. - Common Stock (NQ: CCCC )
4.380
+0.130
(+3.06%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 25, 2024
Add to My Watchlist
Headline News about C4 Therapeutics, Inc. - Common Stock
Via Benzinga
Key Takeaways From C4 Therapeutics Analyst Ratings
May 09, 2024
Via Benzinga
Breaking Down C4 Therapeutics: 4 Analysts Share Their Views
February 26, 2024
Via Benzinga
Analyst Expectations For C4 Therapeutics's Future
January 29, 2024
Via Benzinga
Capital One Financial To Acquire Discover, Joins SSR Mining And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
February 20, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 15, 2023
Via Benzinga
Dow Jumps Over 200 Points; Federal Reserve Holds Interest Rates Steady
December 13, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 13, 2023
Via Benzinga
US Stocks Mixed; Producer Prices Unchanged For November
December 13, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 13, 2023
Via Benzinga
Why ReShape Lifesciences Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
December 13, 2023
Via Benzinga
Exposures
Product Safety
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
December 12, 2023
Via Benzinga
Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results
December 12, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities
US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November
December 12, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free